IL2 and melanoma: As IL-2 could promote the proliferation and activation of NK cells, the absolute amount of NK cells (CD3−NK1.1+) in murine melanoma tumors (B16-F10 cells) after treatment with NRP+I was 1.6 and 1.5 times higher than PTX + IL-2 and NRI groups, respectively.